In The Eye Of Economic Storm, CooperVision Sales Growth Stagnates
This article was originally published in The Gray Sheet
Executive Summary
The Cooper Companies' core contact lens business has taken a hit in recent months from the recession, but it expects new products to spur sales growth, the firm said during a Dec. 9 fourth-quarter and year-end earnings call
You may also be interested in...
Cooper’s Two-Week Silicone Hydrogel Contact Lens Is Wild Card For 2008
CooperVision's planned spring launch of a two-week silicone hydrogel contact lens could enhance revenue expectations of parent firm Cooper Companies in 2008
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.